CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2021$1,560,000
+42.9%
433,4000.0%0.00%0.0%
Q4 2020$1,092,000
-2.1%
433,400
-2.1%
0.00%0.0%
Q3 2020$1,115,000
-21.2%
442,500
+2.6%
0.00%0.0%
Q2 2020$1,415,000
+58.8%
431,400
+18.6%
0.00%0.0%
Q1 2020$891,000
-48.1%
363,7940.0%0.00%
-50.0%
Q4 2019$1,717,000
+34.9%
363,794
+22.3%
0.00%
+100.0%
Q3 2019$1,273,000
-1.0%
297,394
+34.9%
0.00%
-50.0%
Q2 2019$1,286,000
+76.9%
220,498
+16.8%
0.00%
+100.0%
Q1 2019$727,000
+105.9%
188,7660.0%0.00%
Q4 2018$353,000
-41.6%
188,7660.0%0.00%
-100.0%
Q3 2018$604,000
-9.7%
188,766
-14.8%
0.00%0.0%
Q2 2018$669,000
-20.0%
221,552
+3.9%
0.00%0.0%
Q1 2018$836,000
-5.3%
213,1660.0%0.00%0.0%
Q4 2017$883,000
-32.5%
213,1660.0%0.00%
-50.0%
Q3 2017$1,309,000
-1.3%
213,1660.0%0.00%0.0%
Q2 2017$1,326,000
-47.8%
213,166
-51.1%
0.00%
-50.0%
Q1 2017$2,541,000
+113.5%
435,532
+95.9%
0.00%
+100.0%
Q4 2016$1,190,000
-5.0%
222,3660.0%0.00%0.0%
Q3 2016$1,252,000
-4.1%
222,366
-6.4%
0.00%0.0%
Q2 2016$1,305,000
-28.2%
237,666
-3.0%
0.00%
-33.3%
Q1 2016$1,818,000
-28.8%
245,066
-20.3%
0.00%
-25.0%
Q4 2015$2,554,000
+515.4%
307,366
+567.2%
0.00%
+300.0%
Q3 2015$415,000
+3672.7%
46,066
+1488.5%
0.00%
Q3 2013$11,000
+83.3%
2,9000.0%0.00%
Q2 2013$6,0002,9000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders